Jaguar Health Inc
General ticker "JAGX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $9.3M
Jaguar Health Inc does not follow the US Stock Market performance with the rate: -28.7%.
Estimated limits based on current volatility of 6.0%: low 0.86$, high 0.97$
Short-term JAGX quotes
Long-term JAGX plot
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $4.33MM | $11.96MM | $9.76MM |
Operating Expenses | $45.04MM | $46.37MM | $44.05MM |
Operating Income | $-40.71MM | $-34.41MM | $-34.29MM |
Non-Operating Income | $-11.89MM | $-13.98MM | $-7.61MM |
Interest Expense | $8.42MM | $12.72MM | $6.38MM |
R&D Expense | $15.08MM | $17.65MM | $18.60MM |
Income(Loss) | $-52.60MM | $-48.40MM | $-41.90MM |
Taxes | $0.00MM | $0.00MM | $-0.60MM |
Profit(Loss) | $-52.60MM | $-48.40MM | $-41.30MM |
Stockholders Equity | $11.85MM | $-1.36MM | $4.96MM |
Inventory | $4.90MM | $7.02MM | $9.19MM |
Assets | $53.27MM | $47.45MM | $50.76MM |
Operating Cash Flow | $-34.97MM | $-33.10MM | $-33.24MM |
Capital expenditure | $0.01MM | $1.68MM | $0.00MM |
Investing Cash Flow | $-0.01MM | $-1.68MM | $0.00MM |
Financing Cash Flow | $43.94MM | $23.18MM | $34.23MM |
Earnings Per Share* | $-101.07 | $-36.18 | $-107.42 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.